Assessing the Dynamics and Complexity of Disease Pathogenicity Using 4-Dimensional Immunological Data.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2019
Historique:
received: 19 01 2019
accepted: 17 05 2019
entrez: 29 6 2019
pubmed: 30 6 2019
medline: 21 10 2020
Statut: epublish

Résumé

Investigating disease pathogenesis and personalized prognostics are major biomedical needs. Because patients sharing the same diagnosis can experience different outcomes, such as survival or death, physicians need new personalized tools, including those that rapidly differentiate several inflammatory phases. To address these topics, a pattern recognition-based method (PRM) that follows an inverse problem approach was designed to assess, in <10 min, eight concepts

Identifiants

pubmed: 31249569
doi: 10.3389/fimmu.2019.01258
pmc: PMC6582751
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1258

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI130473
Pays : United States

Références

Crit Care Med. 2000 Jul;28(7):2193-200
pubmed: 10921540
Bioessays. 2001 Jan;23(1):104-107
pubmed: 11135315
Am J Vet Res. 2001 Dec;62(12):1840-51
pubmed: 11763169
Nature. 2002 Dec 19-26;420(6917):860-7
pubmed: 12490959
Trends Biotechnol. 2004 Sep;22(9):446-50
pubmed: 15331224
Crit Rev Toxicol. 2006 Apr;36(4):359-85
pubmed: 16809103
Nat Biotechnol. 2008 Mar;26(3):303-4
pubmed: 18327243
Int J Health Geogr. 2008 Nov 18;7:58
pubmed: 19017406
Epidemiol Infect. 2010 Feb;138(2):192-8
pubmed: 19653927
Metabolomics. 2010 Mar;6(1):3-17
pubmed: 20339444
Perspect Biol Med. 2010 Summer;53(3):330-40
pubmed: 20639603
Clin Chem Lab Med. 2011 Mar;49(3):493-9
pubmed: 21275817
J Theor Biol. 2011 May 7;276(1):269-76
pubmed: 21315730
Virol J. 2011 May 13;8:223
pubmed: 21569520
Semin Cancer Biol. 2011 Jun;21(3):165-74
pubmed: 21569848
Semin Cancer Biol. 2011 Jun;21(3):156-64
pubmed: 21729754
J Math Biol. 2013 Jul;67(1):143-68
pubmed: 22526835
PLoS One. 2012;7(6):e39778
pubmed: 22761900
Front Immunol. 2013 Jan 21;3:427
pubmed: 23346088
BMJ. 2013 Feb 05;346:e5595
pubmed: 23386360
PLoS One. 2013;8(2):e53984
pubmed: 23437039
Transbound Emerg Dis. 2015 Aug;62(4):437-45
pubmed: 24024609
Med Image Anal. 2014 Jan;18(1):176-96
pubmed: 24231667
Cytokine. 2014 Feb;65(2):184-91
pubmed: 24290866
Proc Natl Acad Sci U S A. 2014 May 13;111(19):7114-9
pubmed: 24778254
J Gerontol A Biol Sci Med Sci. 2014 Jun;69 Suppl 1:S4-9
pubmed: 24833586
BMJ. 2014 Jun 13;348:g3725
pubmed: 24927763
Methods Mol Biol. 2014;1175:3-17
pubmed: 25150863
Front Immunol. 2014 Oct 07;5:491
pubmed: 25339958
Clin Transl Immunology. 2014 May 16;3(5):e15
pubmed: 25505963
BMC Med. 2015 Jan 30;13:20
pubmed: 25637245
Curr Pharm Des. 2015;21(16):2122-30
pubmed: 25760335
PLoS One. 2015 Apr 14;10(4):e0123674
pubmed: 25875169
R Soc Open Sci. 2014 Oct 01;1(2):140172
pubmed: 26064538
J Int AIDS Soc. 2015 Jun 29;18:20052
pubmed: 26130226
PLoS One. 2015 Sep 11;10(9):e0137721
pubmed: 26361390
BMC Infect Dis. 2015 Oct 27;15:464
pubmed: 26503619
Genetics. 2016 Jan;202(1):285-95
pubmed: 26564159
Brief Bioinform. 2017 Jan;18(1):105-124
pubmed: 26876889
Sci Rep. 2016 Jun 02;6:25696
pubmed: 27254731
Front Immunol. 2016 Jun 10;7:217
pubmed: 27375617
PLoS One. 2016 Jul 13;11(7):e0159001
pubmed: 27411058
AJR Am J Roentgenol. 2017 Apr;208(4):754-760
pubmed: 28125274
Front Immunol. 2017 May 31;8:612
pubmed: 28620378
Integr Med Res. 2014 Dec;3(4):211-216
pubmed: 28664100
Angiology. 2018 Aug;69(7):600-608
pubmed: 29202601
Front Immunol. 2017 Dec 20;8:1866
pubmed: 29326724
Front Immunol. 2018 Jan 12;8:2009
pubmed: 29387066
Front Immunol. 2018 Apr 04;9:595
pubmed: 29670613
Front Cell Infect Microbiol. 2018 May 23;8:169
pubmed: 29930915
Eur Radiol. 2019 Mar;29(3):1616-1624
pubmed: 30105410
J Infect Dis. 2018 Aug 14;218(suppl_1):S7-S11
pubmed: 30124977
EMBO Rep. 2019 Apr;20(4):null
pubmed: 30926631

Auteurs

Ariel L Rivas (AL)

School of Medicine, Center for Global Health-Division of Infectious Diseases, University of New Mexico, Albuquerque, NM, United States.

Almira L Hoogesteijn (AL)

Human Ecology, Centro de Investigación y de Estudios Avanzados (CINVESTAV), Mérida, Mexico.

Athos Antoniades (A)

Stremble Ventures LTD, Limassol, Cyprus.

Marios Tomazou (M)

Stremble Ventures LTD, Limassol, Cyprus.

Tione Buranda (T)

Department of Pathology, School of Medicine, University of New Mexico, Albuquerque, NM, United States.

Douglas J Perkins (DJ)

School of Medicine, Center for Global Health-Division of Infectious Diseases, University of New Mexico, Albuquerque, NM, United States.

Jeanne M Fair (JM)

Biosecurity and Public Health, Los Alamos National Laboratory, Los Alamos, NM, United States.

Ravi Durvasula (R)

Loyola University Medical Center, Chicago, IL, United States.

Folorunso O Fasina (FO)

Department of Veterinary Tropical Diseases, University of Pretoria, Pretoria, South Africa.
Food and Agriculture Organization of the United Nations, Dar es Salaam, Tanzania.

George P Tegos (GP)

GAMA Therapeutics LLC, Mansfield, MA, United States.

Marc H V van Regenmortel (MHV)

Centre National de la Recherche Scientifique (CNRS), School of Biotechnology, University of Strasbourg, Strasbourg, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH